Clinical Trial Update: Hpx•apoB Product as a Biomarker for Coronary Artery Disease

View source ↗

Summary

A completed clinical trial evaluated the Hpx•apoB product as a biomarker for Coronary Artery Disease. The study was conducted under sponsor Shiyan City Renmin H…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Hpx•apoB Product

Snippet

Sponsor: Shiyan City Renmin Hospital | Conditions: Coronary Artery Disease | Status: COMPLETED